Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ALTU-238 PK/PD Study in Adult Growth Hormone Deficiency
NCT00297713Phase 2Completed
- Sponsor
- Altus Pharmaceuticals Inc.
- Start
- Jul 2005
- Modality
- rProtein (Recombinant Protein), Biologic
- Countries
- 1
01
Overview
A Phase 2 trial of somatropin (ALTU-238) in growth hormone deficiency (GHD), sponsored by Altus Pharmaceuticals Inc.. Started Jul 2005; status: completed.
02
Drugs
somatropin (ALTU-238)
03
Conditions
growth hormone deficiency (GHD)
Beyond the preview
Go deeper on NCT00297713.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00297713.